Screener
Assembly Biosciences ASMB Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Assembly Biosciences’s 10-Q, filed August 13, 2026. Open the filing →
- Filed
- Aug 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-349236
FAQ
- What is Assembly Biosciences's net income?
- Assembly Biosciences (ASMB) reported net income of -$3.86M in Q2 2026.
- How has Assembly Biosciences's net income changed year-over-year?
- Assembly Biosciences's net income increased by 62.2% year-over-year, from -$10.2M to -$3.86M.
- What is the long-term trend for Assembly Biosciences's net income?
- Over 3 years (2021 to 2024), Assembly Biosciences's net income has grown at a -32.4% compound annual growth rate (CAGR), from -$129.86M to -$40.18M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Assembly Biosciences's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude